A role for the C3a anaphylatoxin receptor in the effector phase of asthma

Alison A. Humbles, Bao Lu, Christy A. Nilsson, Craig Lilly, Elliot Israel, Yuko Fujiwara, Norma P. Gerard and Craig Gerard ()
Additional contact information
Alison A. Humbles: Ina Sue Perlmutter Laboratory, Children's Hospital, Harvard Medical School
Bao Lu: Ina Sue Perlmutter Laboratory, Children's Hospital, Harvard Medical School
Christy A. Nilsson: Ina Sue Perlmutter Laboratory, Children's Hospital, Harvard Medical School
Craig Lilly: Brigham and Women's Hospital, Harvard Medical School
Elliot Israel: Brigham and Women's Hospital, Harvard Medical School
Yuko Fujiwara: Harvard Medical School
Norma P. Gerard: Ina Sue Perlmutter Laboratory, Children's Hospital, Harvard Medical School
Craig Gerard: Ina Sue Perlmutter Laboratory, Children's Hospital, Harvard Medical School

Nature, 2000, vol. 406, issue 6799, 998-1001

Abstract: Abstract Asthma is a chronic inflammatory disease of the airways and lung mucosa with a strong correlation to atopy and acquired (IgE) immunity1. However, many features of bronchial asthma, such as smooth muscle contraction, mucus secretion and recruitment of inflammatory cells, are consistent with the actions of complement anaphylatoxins, in particular C3a and C5a2. Complement activation forms a central core of innate immune defence against mucosal bacteria, viruses, fungi, helminths and other pathogens. As a system of ‘pattern-recognition molecules’, foreign surface antigens and immune complexes lead to a proteolytic cascade culminating in a lytic membrane attack2,3. The anaphylatoxins C3a and C5a are liberated as activation byproducts and are potent pro-inflammatory mediators that bind to specific cell surface receptors and cause leukocyte activation, smooth muscle contraction and vascular permeability2. Here we show that in a murine model of allergic airway disease, genetic deletion of the C3a receptor protects against the changes in lung physiology seen after allergen challenge. Furthermore, human asthmatics develop significant levels of ligand C3a following intra-pulmonary deposition of allergen, but not saline. We propose that, in addition to acquired immune responses, the innate immune system and complement (C3a in particular) are involved in the pathogenesis of asthma.

Date: 2000
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/35023175 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:406:y:2000:i:6799:d:10.1038_35023175

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35023175

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().